Long-Term Effects of Metabolic Stress on Human Malignant Melanoma Cell Line

被引:0
|
作者
Nakhjavani, Maryam [1 ]
Shirazi, Farshad H. [1 ,2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Shahid Beheshti Sch Pharm, Dept Tox Pharmacol, Tehran, Iran
[2] Shahid Beheshti Med Univ, Pharmaceut Sci Res Ctr, Tehran, Iran
关键词
A375; Neoplasm; Serum; Starvation; Metabolic Stress; HUMAN LUNG; CANCER; RESISTANCE; HETEROGENEITY; CYTOTOXICITY; DERIVATIVES; EXPOSURE; BIOLOGY; GROWTH; LEVEL;
D O I
10.5530/ijper.52.4.70
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Introduction: Tumour is a heterogeneous tissue consisting of cells with different levels of metabolic activity. Often the outer layer cells of a tumour have more optimal conditions to grow/proliferate compared to the inner cells. Objective: The aim of the current study was to study the reactions of malignant melanoma A375 cells in exposure to different levels of metabolic stress and their ability to returning to life upon re-exposure to optimum nutritional conditions. Methods: A375 cells, at early plateau phase, were exposed to media containing 10% (control), 0.5, 0.25 and 0% serum for 1 to 6 days. At 24 h intervals, the cells were tested for morphology, cell cycle distribution, cell size changes, cell count, mitochondrial function and protein content. Also, after each day of starvation, the cells were re-exposed to optimum media (10% serum) and tested again. Results: The results showed that the cells made foci structures at long-term starvation. They primarily accumulated in G1-phase and at long-term starvation, most of them entered the apoptotic state. However, before death, cell count did not decrease, even though the mitochondrial function and protein content were less than the control cells. Releasing the cells in optimum conditions could trigger cells' proliferation ability, mitochondrial function and protein content. Conclusion: The results suggest that this model of malignant melanoma has a resistant feature against sub-optimal nutritional and metabolic status and the cells can return to life with even stronger internal engines, as evidenced by higher levels of mitochondrial function and protein content.
引用
收藏
页码:602 / 609
页数:8
相关论文
共 50 条
  • [21] METABOLIC EFFECTS OF LONG-TERM CORTISONE THERAPY
    CALKINS, E
    MITCHELL, DM
    BAUER, W
    ANNALS OF THE RHEUMATIC DISEASES, 1954, 13 (04) : 352 - 353
  • [22] Long-term effects on metabolic control and BMI
    Biesenbach, G.
    Bodlaj, G.
    Sedlak, M.
    Pieringer, H.
    Kiesling, G.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2009, 42 (06): : 465 - 469
  • [23] METABOLIC EFFECTS OF LONG-TERM GLUCAGON INFUSION
    FREY, H
    FALCH, D
    FORFANG, K
    NORMAN, N
    FREMSTAD, D
    DIABETOLOGIA, 1971, 7 (05) : 403 - &
  • [24] LONG-TERM TRENDS IN DESCRIPTIVE EPIDEMIOLOGY OF MALIGNANT MELANOMA IN THE SLOVAK REPUBLIC
    Ondrusova, M.
    Psenkova, M.
    Suchansky, M.
    VALUE IN HEALTH, 2015, 18 (07) : A431 - A431
  • [25] Long-Term Survival After Pneumonectomy for Primary Pulmonary Malignant Melanoma
    Mahowald, Madeline K.
    Aswad, Bassam I.
    Okereke, Ikenna C.
    Ng, Thomas
    ANNALS OF THORACIC SURGERY, 2015, 99 (04): : 1428 - 1430
  • [26] Oral malignant melanoma: long-term follow up in three patients
    Tanaka, N
    Nagai, I
    Hiratsuka, H
    Kohama, G
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1998, 27 (02) : 111 - 114
  • [27] Cobimetinib in malignant melanoma: how to MEK an impact on long-term survival
    Indini, Alice
    Tondini, Carlo Alberto
    Mandala, Mario
    FUTURE ONCOLOGY, 2019, 15 (09) : 967 - 978
  • [28] A REVERSAL IN THE LONG-TERM INCREASE IN DEATHS ATTRIBUTABLE TO MALIGNANT-MELANOMA
    ROUSH, GC
    MCKAY, L
    HOLFORD, TR
    CANCER, 1992, 69 (07) : 1714 - 1720
  • [29] Long-Term Survival After Brain and Spine Metastasis in Malignant Melanoma
    Rustagi, Tarush
    Yener, Ulas
    Blakaj, Dukagjin
    Kenda, Kari
    Mendel, Ehud
    WORLD NEUROSURGERY, 2019, 125 : 164 - 169
  • [30] Long-term survival of a female patient with primary malignant melanoma of the urethra
    Rikaniadis, N
    Konstadoulakis, MM
    Kymionis, GD
    Tsibloulis, B
    Peveretos, P
    Karakousis, CP
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1998, 24 (06): : 607 - 608